ICTV Virus Taxonomy Profile: Filoviridae.


Journal

The Journal of general virology
ISSN: 1465-2099
Titre abrégé: J Gen Virol
Pays: England
ID NLM: 0077340

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 26 4 2019
medline: 19 2 2020
entrez: 26 4 2019
Statut: ppublish

Résumé

Members of the family Filoviridae produce variously shaped, often filamentous, enveloped virions containing linear non-segmented, negative-sense RNA genomes of 15-19 kb. Several filoviruses (e.g., Ebola virus) are pathogenic for humans and are highly virulent. Several filoviruses infect bats (e.g., Marburg virus), whereas the hosts of most other filoviruses are unknown. This is a summary of the International Committee on Taxonomy of Viruses (ICTV) Report on Filoviridae, which is available at www.ictv.global/report/filoviridae.

Identifiants

pubmed: 31021739
doi: 10.1099/jgv.0.001252
pmc: PMC7011696
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

911-912

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272200700016I
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Wellcome Trust
ID : WT108418AIA
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States

Références

PLoS Biol. 2011 Nov;9(11):e1001196
pubmed: 22110401
Curr Top Microbiol Immunol. 2017;411:381-417
pubmed: 28795188
Nature. 2018 Apr;556(7700):197-202
pubmed: 29618816
Nature. 2018 Nov;563(7729):137-140
pubmed: 30333622

Auteurs

Jens H Kuhn (JH)

1​NIH/NIAID Integrated Research Facility at Fort Detrick, (IRF-Frederick), Frederick, MD 21702, USA.

Gaya K Amarasinghe (GK)

2​Washington University School of Medicine, St. Louis, MO 63110, USA.

Christopher F Basler (CF)

3​Center for Microbial Pathogenesis, Georgia State University, Atlanta GA 30303, USA.

Sina Bavari (S)

4​United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.

Alexander Bukreyev (A)

5​The University of Texas Medical Branch, Galveston, TX 77555, USA.

Kartik Chandran (K)

6​Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Ian Crozier (I)

7​Integrated Research Facility at Fort Detrick, Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research supported by the National Cancer Institute, Frederick, MD 21702, USA.

Olga Dolnik (O)

8​Institute of Virology, Philipps University Marburg, 35043 Marburg, Germany.

John M Dye (JM)

4​United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.

Pierre B H Formenty (PBH)

9​World Health Organization, CH-1211 Geneva, Switzerland.

Anthony Griffiths (A)

10​Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, MA 02118, USA.

Roger Hewson (R)

11​Public Health England, Porton Down, Wiltshire, SP4 0JG Salisbury, UK.

Gary P Kobinger (GP)

12​Université Laval, Québec City, QC G1V 0A6, Canada.

Eric M Leroy (EM)

13​Infectious Diseases and Vectors Unit, Institut de Recherche pour le Développement, 911 Av Agropolis, 34394 Montpellier, France.

Elke Mühlberger (E)

10​Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, MA 02118, USA.

Sergey V Netesov Нетёсов Сергей Викторович (SV)

14​Novosibirsk State University, Novosibirsk, Novosibirsk Oblast, 630090, Russia.

Gustavo Palacios (G)

4​United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.

Bernadett Pályi (B)

15​National Biosafety Laboratory, National Public Health Center, Budapest, Hungary.

Janusz T Pawęska (JT)

16​National Institute for Communicable Diseases of the National Health Laboratory Service, 2131 Sandringham-Johannesburg, Gauteng, South Africa.

Sophie J Smither (SJ)

17​Defence Science and Technology Laboratory, Porton Down, Salisbury, Wiltshire SP4 0JQ, UK.

Ayato Takada 高田礼人 (A)

18​Division of Global Epidemiology, Hokkaido University Research Center for Zoonosis Control, 001-0020 Sapporo, Japan.

Jonathan S Towner (JS)

19​Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

Victoria Wahl (V)

20​National Biodefense Analysis and Countermeasures Center, Frederick, MD 21702, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH